Search - tctmd.com

Displaying 601 - 620 of 765

Sort: Relevancy | Date

Presentation TCT 2016

TCT 546: Imaging and Physiology-Guided Zero Contrast Percutaneous Coronary Intervention in Advanced Chronic Kidney Disease

Presenter: Joseph P. Carrozza Jr, Charles J. Davidson

October 30, 2016

Presentation TVT 2016

Advanced CT-Based Image Analyses to Optimize TAVR Positioning

Presenter: Philipp Blanke

June 17, 2016

Presentation TVT 2016

Advanced MitraClip Grasping: Tips and Tricks

Presenter: Ralph Stephan von Bardeleben

June 16, 2016

Presentation TVT 2016

Advanced MitraClip Steering: Tips and Tricks

Presenter: James B. Hermiller Jr

June 16, 2016

Presentation TVT 2016

Expanding the Anatomical Limits for the MitraClip in FMR and DMR

Presenter: Samir R. Kapadia

June 16, 2016

Presentation CCVVC 2016

Top 10 Advances of Interventional Cardiology 2015

Presenter: Samin K Sharma

June 16, 2016

Presentation CCVVC 2016

Advancements in the Treatment Options for ISRLaser, DCB, DES

Presenter: Craig M. Walker

June 15, 2016

Presentation ECHO 2016

Assessing LV Function: Basic to Advanced

Presenter: James D. Thomas

March 22, 2016

Presentation ECHO 2016

An Update on 3D Echo: Advances in Technology

Presenter: James D. Thomas

March 22, 2016

Presentation TCT 2015

Stem CellBased Ablation for Ventricular Arrhythmias

Presenter: Nabil Dib, Philippe Menasché, Angel Arenal

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

Presenter: Nabil Dib, Philippe Menasché, Marc S. Penn

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

Presenter: Nabil Dib, Philippe Menasché, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Jay H Traverse

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Amit Patel

October 15, 2015

Presentation TCT 2015

NuPulse iVAS - A Minimally Invasive Advanced CHF Device

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde

October 14, 2015

Presentation TCT 2015

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? No, It Is Too Complex and There Is No Advantage for the Patient!

Presenter: William A. Gray, D. Christopher Metzger, Bernhard Reimers

October 14, 2015

Presentation TCT 2015

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? Yes, It Is a Game Changer for Both Outcomes and Adoption of Carotid Stenting!

Presenter: William A. Gray, D. Christopher Metzger, Christopher J. Kwolek

October 14, 2015

Presentation TCT 2015

Advanced Stent Designs and Technologies: What Is Coming to the USA?

Presenter: Larry S. Dean, Simon R. Dixon, David E. Kandzari

October 14, 2015

Presentation TCT 2015

Advanced Patient Radiation Management (eg, Follow-up)

Presenter: Stephen Balter, Edwin M. Leidholdt, Jr.

October 13, 2015

Presentation TCT 2015

Advanced iFR: Lesion Assessment Using iFR/FFR Pullback

Presenter: Sergio B Baptista, Eric Van Belle, Justin E. Davies

October 12, 2015

Advertisement

TCT 546: Imaging and Physiology-Guided Zero Contrast Percutaneous Coronary Intervention in Advanced Chronic Kidney Disease

Advanced CT-Based Image Analyses to Optimize TAVR Positioning

Advanced MitraClip Grasping: Tips and Tricks

Advanced MitraClip Steering: Tips and Tricks

Expanding the Anatomical Limits for the MitraClip in FMR and DMR

Top 10 Advances of Interventional Cardiology 2015

Advancements in the Treatment Options for ISRLaser, DCB, DES

Assessing LV Function: Basic to Advanced

An Update on 3D Echo: Advances in Technology

Stem CellBased Ablation for Ventricular Arrhythmias

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

NuPulse iVAS - A Minimally Invasive Advanced CHF Device

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? No, It Is Too Complex and There Is No Advantage for the Patient!

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? Yes, It Is a Game Changer for Both Outcomes and Adoption of Carotid Stenting!

Advanced Stent Designs and Technologies: What Is Coming to the USA?

Advanced Patient Radiation Management (eg, Follow-up)

Advanced iFR: Lesion Assessment Using iFR/FFR Pullback

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content